• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Director Sullivan John James gifted 2,000 shares, decreasing direct ownership by 7% to 25,282 units (SEC Form 4)

    12/5/25 11:10:57 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sullivan John James

    (Last) (First) (Middle)
    12100 W. 6TH AVENUE

    (Street)
    LAKEWOOD CO 80228

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    MESA LABORATORIES INC /CO/ [ MLAB ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    12/02/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 12/02/2025 G 2,000 D $0 25,282 D
    Common Stock 44,780 I By Trust(1)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents shares held in a spousal lifetime access trust
    John Sakys under Power of Attorney by John Sullivan 12/05/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MLAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/7/2025$67.00Underweight → Equal Weight
    Wells Fargo
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026

    LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) --  - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern Time (ET) on Tuesday, February 3, 2026. About Mesa LaboratoriesMesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. Mesa Laboratories ContactsGary Owen

    12/3/25 5:35:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences

    LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences: Raymond James Napa Valley Small Cap SymposiumFormat: 1x1 Meetings Date: Monday, November 17, 2025Jefferies London Healthcare Conference Format: Fireside chatDate: Thursday, November 20, 2025Time: 12:00 p.m. GMTWebcast: Click Here 8th Annual Evercore Healthcare ConferenceFormat: Fireside chat Date: Wednesday, December 3, 2025Time: 2:10 p.m. ET The Jefferies London Healthcare Conference fireside chat will be accessible via live webcast here, and a replay will be available on th

    11/12/25 3:14:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Labs Announces Second Quarter Results

    LAKEWOOD, Colo., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter ("2Q26") ended September 30, 2025 (amounts in thousands). Financial Summary – 2Q26 versus the same year ago period Revenues increased 5.0%Non-GAAP core organic revenues1 growth was 3.7%Operating income increased 34.7% to $4,724 Non-GAAP adjusted operating income ("AOI") excluding unusual items2 increased 6.1% and was 25.1% as a percentage of revenues    We operate a diversified business across four divisions: Ster

    11/6/25 4:15:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    SEC Filings

    View All

    SEC Form 10-Q filed by Mesa Laboratories Inc.

    10-Q - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    11/6/25 4:51:17 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    11/6/25 4:22:17 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Mesa Laboratories Inc.

    SCHEDULE 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    10/31/25 11:02:31 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sullivan John James gifted 2,000 shares, decreasing direct ownership by 7% to 25,282 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    12/5/25 11:10:57 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    President and CEO Owens Gary M converted options into 11,558 shares, increasing direct ownership by 22% to 64,135 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    10/28/25 3:08:05 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Ladiwala Shiraz Shabanali converted options into 1,949 shares, increasing direct ownership by 63% to 5,023 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    8/18/25 2:37:17 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mesa Laboratories upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Mesa Laboratories from Underweight to Equal Weight and set a new price target of $67.00

    8/7/25 7:05:04 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Wells Fargo initiated coverage on Mesa Laboratories with a new price target

    Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

    8/28/24 7:48:06 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

    1/4/24 8:29:10 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Financials

    Live finance-specific insights

    View All

    MESA LABS DECLARES QUARTERLY DIVIDEND

    Lakewood, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2025, to shareholders of record at the close of business on November 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in

    10/3/25 11:01:27 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, inc

    7/3/25 12:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

    4/7/25 3:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Leadership Updates

    Live Leadership Updates

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Mesa Laboratories Appoints Mark Capone to its Board of Directors

    LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa", "we", "us", or "our"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the "Board"), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board of Directors, stated: "We are pleased to welcome Mark to Mesa's Board. Mark is an accomplished life sciences executive with significant leadership and acquisitions experience spanning biopharmaceuticals, life science tools, and clinical genomics. We believe Mark's insights will be pivotal to Mesa

    1/8/24 8:00:00 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

    LAKEWOOD, Colo., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or the "Company") today announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors ("Board"), effective November 3, 2022. Mr. Ladiwala assumes this newly re-created role as an expansion of his current responsibilities on the Board, on which he has served since October 2021. Mr. Ladiwala was selected for this important role due to the thoughtful leadership and contributions he has made to the Board as well as the exceptional breadth of his professional experience. Mr. Ladiwala said, "I am delighted to accept this leadership role on Mes

    11/4/22 3:49:04 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    10/15/24 1:29:56 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    2/13/24 5:09:39 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    1/23/24 2:18:26 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials